Doherty Catherine T.'s Form 4 filing
Quest Diagnostics Inc (DGX) · filed Nov 29, 2022
- Accession no.
- 0001022079-22-000168
- Filed
- Nov 29, 2022
- Trade date
- Nov 28, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $6.08M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Doherty Catherine T.CIK 0001520897 | Officer (SVP, Regional Businesses) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 28, 2022 | Common Stock | MOption exerciseAcquired | +40,765 | $86.63 | +$3,531,471.95 | 108,498 | Direct | |
| Nov 28, 2022 | Common Stock | SSaleDisposed | −17,358 | $148.92F2 | −$2,584,953.36 | 91,140 | Direct | |
| Nov 28, 2022 | Common Stock | SSaleDisposed | −23,407 | $149.37F3 | −$3,496,303.59 | 67,733 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 28, 2022 | Common Stock | MOption exerciseDisposed | −40,765 | $86.63 | −$3,531,471.95 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $148.120 to $149.110. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $149.120 to $149.860. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.